Clinical trial
The Efficacy and Safety of the COMBO Endoscopy Oropharyngeal Airway Reduce the Incidence of Hypoxia in Patients Undergoing Gastrointestinal Endoscopy Sedated With Propofol.
NCT06081647 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy and Safety of the COMBO Endoscopy Oropharyngeal Airway Reduce the Incidence of Hypoxia in Patients Undergoing Gastrointestinal Endoscopy Sedated With Propofol.
- Lead sponsor
- RenJi Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 27, 2023
- Completion date
- December 27, 2025
- Enrollment
- 1,200 (estimated)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
colon cancer, esophageal cancer, gastric polyp, hypoxia